A few weeks back, i looked at other Iron chelator drugs (of which there are only 2), and they are seeing CAGR increases of 16% per year...so yeh, ATH is aiming at MSA with est. $1b US market yearly, add potential/likely PD $6b US market per year than ODD of 7yrs, yeh, huge market.
Hang in there holders.
What to hopefully look forward too, page-3
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 20227248 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 128657356 | 26 |
View Market Depth
| Last trade - 10.03am 04/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |
Day chart unavailable